Humanigen Inc (HGENQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Humanigen Cash from Financing (Quarterly): 0.00 for March 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -5.012M |
| June 30, 2022 | 3.475M |
| March 31, 2022 | 18.37M |
| December 31, 2021 | 25.78M |
| September 30, 2021 | 3.966M |
| June 30, 2021 | 95.60M |
| March 31, 2021 | 60.98M |
| December 31, 2020 | 0.001M |
| September 30, 2020 | 73.26M |
| June 30, 2020 | 63.67M |
| March 31, 2020 | 0.532M |
| December 31, 2019 | 0.535M |
| September 30, 2019 | 0.245M |
| June 30, 2019 | 2.50M |
| March 31, 2019 | 0.05M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 3.025M |
| June 30, 2018 | 0.58M |
| March 31, 2018 | 2.651M |
| December 31, 2017 | 1.58M |
| September 30, 2017 | 5.00M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.00 |
| March 31, 2017 | 5.50M |
| December 31, 2016 | 3.003M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 12.33M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 8.218M |
| September 30, 2015 | -9.155M |
| June 30, 2015 | -1.294M |
| March 31, 2015 | -1.295M |
| December 31, 2014 | -1.282M |
| September 30, 2014 | -1.294M |
| June 30, 2014 | 4.19M |
| March 31, 2014 | -0.752M |
| December 31, 2013 | 31.97M |
| September 30, 2013 | 0.058M |
| June 30, 2013 | -0.433M |
| March 31, 2013 | 64.41M |
| December 31, 2012 | 4.211M |
| September 30, 2012 | 3.902M |
| June 30, 2012 | 18.31M |
| March 31, 2012 | 0.021M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.012M
Minimum
Sep 2022
95.60M
Maximum
Jun 2021
21.49M
Average
2.988M
Median
Cash from Financing (Quarterly) Benchmarks
| Item 9 Labs Corp | -0.005M |
| Green Hygienics Holdings Inc | 0.0448M |
| Cantabio Pharmaceuticals Inc | 0.52M |
| Affymax Inc | -- |
| Statera BioPharma Inc | 0.7117M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.059M |
| Free Cash Flow | -64.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0593 |
| Free Cash Flow to Equity (Quarterly) | -7.059M |